##### Table of Contents



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
 Washington, D.C. 20549
 FORM 10-K/A
 Amendment No. 1
  þ
    
    ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 For the fiscal year ended December 31, 2010
 or
 o
    
    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 For the transition period from            to
 Commission file number: 000-54192
 REVA MEDICAL, INC.
 (Exact name of registrant as specified in its charter)
 Delaware
    
    33-0810505(State or other jurisdiction of
    
    (I.R.S. Employerincorporation or organization)
    
    Identification No.)
 5751 Copley Drive, Suite B, San Diego, CA
    
    92111(Address of principal executive offices)
    
    (Zip Code)
 Registrants telephone number, including area code:
(858) 966-3000
 Securities registered pursuant to Section 12(b) of the Act:
 Title of Each Class
    
    Name of Each Exchange on Which RegisteredCommon Stock, $0.0001 par value per share
    
    Australian Securities Exchange
 Securities registered pursuant to Section 12(g) of the Act: None
 o þ
 o þ
 þ o
 o o
 o
  Large accelerated filer   o
    
    Accelerated filer  o
    
    Non-accelerated filer  þ
    
    Smaller reporting company  o(Do not check if a smaller reporting company)
 o  þ
   DOCUMENTS INCORPORATED BY REFERENCE
 Document Description
    
    10-K PartPortions of the registrants notice of annual meeting of
stockholders and proxy statement to be filed pursuant to
Regulation 14A within 120 days after registrants fiscal year
end of December 31, 2010 are incorporated by reference into Part
III of this report
    
    III




---



TABLE OF CONTENTS  PART IVItem 15. Exhibits and Financial Statement SchedulesSIGNATURESINDEX TO EXHIBITSEX-31.1EX-31.2EX-32.1    Table of Contents  Explanatory Note
  
 PART IV
 
 Item 15. Exhibits and Financial Statement Schedules
   
 2.
    
    List of Financial Statement Schedules  All schedules
are omitted because they are not applicable or the
required information is shown in the financial
statements or notes thereto.3.
    
    Exhibits  The exhibits listed in the accompanying
Index to Exhibits are filed or incorporated by
reference as part of this Annual Report on Form 10-K.




---



##### Table of Contents



SIGNATURES
  REVA Medical, Inc.Dated: June 21, 2011
    By:
    /s/ Robert B. StockmanName:
    Robert B. StockmanTitle:
    Chairman of the Board and
Chief Executive Officer  Signature
    
    Title
    
    Date/s/ Robert B. Stockman

Robert B. Stockman
    
    Chairman of the Board and
Chief Executive Officer
(Principal Executive Officer)
    
    June 21, 2011/s/ Katrina Thompson

Katrina Thompson
    
    Chief Financial Officer
(Principal Financial Officer and
Principal Accounting Officer)
    
    June 21, 2011/s/ Robert K. Schultz, Ph.D.

Robert K. Schultz, Ph.D.
    
    President and
Chief Operating Officer
    
    June 21, 2011/s/ Brian Dovey
    
    Director
    
    June 21, 2011Brian Dovey/s/ Anne Keating
    
    Director
    
    June 21, 2011Anne Keating/s/ Gordon E. Nye
    
    Director
    
    June 21, 2011Gordon E. Nye/s/ James J. Schiro
    
    Director
    
    June 21, 2011James J. Schiro/s/ Robert Thomas
    
    Director
    
    June 21, 2011Robert Thomas




---



##### Table of Contents



INDEX TO EXHIBITS
 ExhibitNumber
    
    Description of Exhibits3.1
    
    Amended and Restated Certificate of Incorporation.*3.2
    
    Amended and Restated Bylaws to be effective upon completion of this offering.*4.1
    
    Form of Stock Certificate.*4.2
    
    Form of Amended and Restated Investors Rights Agreement, by and among REVA Medical, Inc. and the
holders of our preferred stock set forth therein.*10.1
    
    Telecom Business Center Business Lease between FSP Telecom Business Center Limited Partnership and
REVA Medical, Inc. dated December 18, 2001.*10.2
    
    First Amendment to Telecom Business Center Business Lease between FSP Telecom Business Center Limited
Partnership and REVA Medical, Inc. dated January 3, 2005.*10.3
    
    Second Amendment to Telecom Business Center Business Lease between ARI Commercial Properties, Inc. and
REVA Medical, Inc. dated February 18, 2006.*10.4
    
    Third Amendment to Telecom Business Center Business Lease between ARI Commercial Properties, Inc. and
REVA Medical, Inc. dated December 14, 2006.*10.5
    
    Fourth Amendment to Telecom Business Center Business Lease between ARI Commercial Properties, Inc. and
REVA Medical, Inc. dated June 7, 2008.*10.6
    
    Agreement and Plan of Merger, dated October 13, 2004, by and among REVA Medical, Inc., Boston
Scientific Corporation, RMI Acquisition Corp. and certain stockholder representatives set forth
therein.*10.7
    
    Amendment No. 1 to the Agreement and Plan of Merger, dated December 7, 2007, by and among REVA
Medical, Inc., Boston Scientific Corporation, RMI Acquisition Corp. and certain stockholder
representatives set forth therein.*10.8
    
    Securities Purchase Agreement between Boston Scientific Corporation and REVA Medical, Inc. dated
October 13, 2004.*10.9
    
    Amendment No. 1 to Securities Purchase Agreement between Boston Scientific Corporation and REVA
Medical, Inc. dated December 7, 2007.*10.10
    
    Distribution Option Agreement, dated December 7, 2007, by and between REVA Medical, Inc. and Boston
Scientific Corporation.*10.11
    
    Exclusive License Agreement Number between Rutgers, The State University of New Jersey and REVA
Medical, Inc. dated July 1, 2010.++*10.12
    
    Royalty and License Agreement between Integra/LifeSciences Corporation and REVA Medical, Inc. dated
February 2, 2004.++*10.13
    
    2001 Stock Option/Stock Issuance Plan.+*10.14
    
    Form of Stock Option Agreement.+*10.15
    
    Form of Addendum to Stock Option Agreement.+*10.16
    
    2010 Equity Incentive Plan.+*10.17
    
    Form of Stock Option Agreement.+*10.18
    
    Form of Stock Option Agreement entered into with Robert Thomas and Anne Keating.+*10.19
    
    Form of Director and Officer Indemnification Agreement.+*10.20
    
    Employment Agreement, dated July 1, 2010, by and between REVA Medical, Inc. and Robert B. Stockman.+*10.21
    
    Employment Agreement, dated October 21, 2010, by and between REVA Medical, Inc. and Robert Schultz.+*10.22
    
    Employment Agreement, dated October 21, 2010, by and between REVA Medical, Inc. and Katrina Thompson.+*10.23
    
    Form of Offer Management Agreement between REVA Medical, Inc. and Inteq Limited.*10.24
    
    Form of CDI Subscription Application for non U.S. investors.*10.25
    
    Form of CDI Subscription Application for U.S. investors.*10.26
    
    Form of Escrow Deed between REVA Medical, Inc. and Computershare Investor Services Pty Limited.*21.1
    
    List of Subsidiaries.*31.1
    
    Certification of Principal Executive Officer Required Under Rule 13a-14(a) and 15d-14(a) of the
Securities Exchange Act of 1934, as amended.31.2
    
    Certification of Principal Financial Officer Required Under Rule 13a-14(a) and 15d-14(a) of the
Securities Exchange Act of 1934, as amended.32.1
    
    Certification of Principal Executive Officer and Principal Financial Officer Required Under
Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. §1350.99.1
    
    Section 13 of the ASX Settlement Rules.*




---



##### Table of Contents



+
    
    Management Compensation Plan++
    
    Confidential Treatment Request*
    
    Filed as exhibits to the registrants
Registration Statement on Form S-1 (File
No. 333-168852), effective November 15, 2010,
and incorporated herein by reference.